Jeffrey Bradley

Affiliations: 
Radiation Oncology Washington University School of Medicine, St. Louis, MO, United States 
Google:
"Jeffrey Bradley"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Friedes C, Iocolano M, Ho Lee S, et al. (2023) The Effective Radiation Dose to Immune Cells Predicts Lymphopenia and Inferior Cancer Control in Locally Advanced NSCLC. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110030
Yegya-Raman N, Ho Lee S, Friedes C, et al. (2023) Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110005
Weidhaas JB, Hu C, Komaki R, et al. (2023) The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer Research Communications
Yegya-Raman N, Berman AT, Ciunci CA, et al. (2023) Phase II trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer: Pembro after PBT ReRT for NSCLC. International Journal of Radiation Oncology, Biology, Physics
Yegya-Raman N, Friedes C, Lee SH, et al. (2023) Pneumonitis rates before and after adoption of immunotherapy consolidation in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiation. International Journal of Radiation Oncology, Biology, Physics
Lee SH, Geng H, Arnold J, et al. (2023) Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617. International Journal of Radiation Oncology, Biology, Physics
Simone CB, Bradley J, Chen AB, et al. (2023) ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer. Practical Radiation Oncology. 13: 195-202
Janopaul-Naylor JR, Cao Y, McCall NS, et al. (2023) Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era. Frontiers in Oncology. 12: 1074675
Bogart J, Wang X, Masters G, et al. (2023) High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201359
McCall NS, Scott McGinnis H, Janopaul-Naylor JR, et al. (2022) Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology
See more...